Company Name: |
Amatek Scientific Co. Ltd.
|
Tel: |
0512-56316828 |
Email: |
info@amateksci.com |
Products Intro: |
Product Name:FmocNH-PEG3-CH2CH2N3 CAS:1172605-58-1 Purity:97% HPLC Package:1g;5g;25g;100g
|
Company Name: |
Suzhou Rovathin Foreign Trade Co.,Ltd
|
Tel: |
0512-65816829 18662214788 |
Email: |
info@rovathin.com.cn |
Products Intro: |
Product Name:13-Azido-5,8,11-trioxa-2-azatridecanoic acid 9H-fluoro-9-yl methyl ester CAS:1172605-58-1 Purity:0.95 Package:1g;10g;100g;1kg
|
Company Name: |
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
|
Tel: |
meitaochem@126.com |
Email: |
meitaochem@126.com |
Products Intro: |
Product Name:13-Azido-5,8,11-trioxa-2-azatridecanoic acid 9H-fluoro-9-yl methyl ester CAS:1172605-58-1 Purity:99% HPLC Package:50G;100G;
|
|
| 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester Basic information |
Product Name: | 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester | Synonyms: | 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester;13-Azido-5,8,11-trioxa-2-azatridecanoic acid 9H-fluoro-9-yl methyl ester;FmocNH-PEG3-CH2CH2N3;FmocNH-PEG3-CH2CH2N3/5,8,11-Trioxa-2-azatridecanoic acid, 13-azido-, 9H-fluoren-9-ylmethyl ester | CAS: | 1172605-58-1 | MF: | C23H28N4O5 | MW: | 440.5 | EINECS: | | Product Categories: | | Mol File: | 1172605-58-1.mol | ![13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester Structure](CAS/20211123/GIF/1172605-58-1.gif) |
| 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester Chemical Properties |
| 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester Usage And Synthesis |
Biological Activity | Fmoc-N-amido-PEG3-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| 13-zido-,,1-rioxa--zatridecanoic acid 9H-luoren--lmethyl ester Preparation Products And Raw materials |
|